DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cellulite and Magnetic Resonance Imaging

Information source: Brazilan Center for Studies in Dermatology
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cellulitis

Phase: N/A

Status: Completed

Sponsored by: Doris Hexsel


The purpose of this study is to compare the anatomy of subcutaneous structures in areas with and without cellulite on the buttocks of same subjects with a non invasive technique, Magnetic Resonance Imaging.

Clinical Details

Official title: Anatomy of Subcutaneous Structures in Areas With and Without Cellulite Depressions by Magnetic Resonance Imaging

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome: The presence and characteristics of the fibrous septa in areas with and without cellulite.

Secondary outcome: The characteristics of the subcutaneous tissue in areas with and without cellulite.

Detailed description: A cross-sectional study was performed at a single center, in accordance with good clinical practice. Thirty women aged 18 to 50 were included in this study. An experienced dermatologist evaluated all of the subjects in a standing position, with relaxed gluteus muscles, using the CSS classification. An area with cellulite and another without cellulite on the contralateral buttock were selected. The area with cellulite had an evident depressed lesion, whereas the area without cellulite had no depressed or raised lesions, The selected cellulite depression was marked with a positive symbol using a skin marking pen.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.


Inclusion Criteria:

- Written Informed Consent;

- Subjects agreeing to take part of all procedures of the study, after being fully

informed on the objectives and nature of the investigations;

- Healthy female subjects over 18 years;

- Subjects presenting cellulite on the buttocks;

- Medical history and physical examination which, based on the investigator's opinion,

do not prevent the patient from taking part in the study and use the product under investigation;

- Female subjects of childbearing age should present a negative urine pregnancy test

and should be using an effective contraceptive method (3 months before the enrollment until the end of the study);

- Availability of the subject throughout the duration of the study (180 days);

- Subjects with sufficient schooling and awareness to enable them to cooperate to the

degree required by this protocol. Exclusion Criteria:

- Pregnant women or women intending to become pregnant during the study (next 3


- Subjects participating in other clinical trials;

- Any condition that, in the opinion of the investigator, can compromise the evaluation

of the study.

Locations and Contacts

Additional Information

Starting date: July 2008
Last updated: February 24, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017